Analyst Estimates: Here's What Brokers Think Of Havas N.V. (AMS:HAVAS) After Its Half-Year Report

Shareholders might have noticed that Havas N.V. (AMS:HAVAS) filed its interim result this time last week. The early response was not positive, with shares down 4.6% to €1.42 in the past week. Results look mixed - while revenue fell marginally short of analyst estimates at €1.3b, statutory earnings were in line with expectations, at €0.17 per share. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

Taking into account the latest results, the current consensus, from the six analysts covering Havas, is for revenues of €2.81b in 2025. This implies a measurable 3.2% reduction in Havas' revenue over the past 12 months. In the lead-up to this report, the analysts had been modelling revenues of €2.82b and earnings per share (EPS) of €0.21 in 2025. Overall, while the analysts have reconfirmed their revenue estimates, the consensus now no longer provides an EPS estimate. This implies that the market believes revenue is more important after these latest results.

Check out our latest analysis for Havas

We'd also point out that thatthe analysts have made no major changes to their price target of €1.92. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. Currently, the most bullish analyst values Havas at €2.30 per share, while the most bearish prices it at €1.45. Analysts definitely have varying views on the business, but the spread of estimates is not wide enough in our view to suggest that extreme outcomes could await Havas shareholders.

Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. Over the past year, revenues have declined around 0.7% annually. Worse, forecasts are essentially predicting the decline to accelerate, with the estimate for an annualised 6.2% decline in revenue until the end of 2025. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to see their revenue grow 1.6% per year. So it's pretty clear that, while it does have declining revenues, the analysts also expect Havas to suffer worse than the wider industry.

The Bottom Line

The most important thing to take away is that the analysts reconfirmed their revenue estimates for next year, suggesting that the business is performing in line with expectations. On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry. The consensus price target held steady at €1.92, with the latest estimates not enough to have an impact on their price targets.

We have estimates for Havas from its six analysts out to 2027, and you can see them free on our platform here.

You can also view our analysis of Havas' balance sheet, and whether we think Havas is carrying too much debt, for free on our platform here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.